ConductScience.org, home

Gene · 3269

Drugs113

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
ACRIVASTINECHEMBL1224Histamine H1 receptor antagonistANTAGONISTChEMBL
ALCAFTADINECHEMBL1201747Histamine H1 receptor antagonistANTAGONISTChEMBL
ANTAZOLINECHEMBL1305Histamine H1 receptor antagonistANTAGONISTChEMBL
ANTAZOLINE PHOSPHATECHEMBL1200550Histamine H1 receptor antagonistANTAGONISTChEMBL
ASTEMIZOLECHEMBL296419Histamine H1 receptor antagonistANTAGONISTChEMBL
AZATADINECHEMBL946Histamine H1 receptor antagonistANTAGONISTChEMBL
AZATADINE MALEATECHEMBL3544908Histamine H1 receptor antagonistANTAGONISTChEMBL
AZELASTINECHEMBL639Histamine H1 receptor antagonistANTAGONISTChEMBL
AZELASTINE HYDROCHLORIDECHEMBL1200809Histamine H1 receptor antagonistANTAGONISTChEMBL
BEPOTASTINECHEMBL1201758Histamine H1 receptor antagonistANTAGONISTChEMBL
BEPOTASTINE BESYLATECHEMBL1201759Histamine H1 receptor antagonistANTAGONISTChEMBL
BETAHISTINECHEMBL24441Histamine H1 receptor agonistAGONISTChEMBL
BILASTINECHEMBL1742423Histamine H1 receptor inverse agonistINVERSE AGONISTChEMBL
BROMODIPHENHYDRAMINECHEMBL1201245Histamine H1 receptor antagonistANTAGONISTChEMBL
BROMODIPHENHYDRAMINE HYDROCHLORIDECHEMBL1200967Histamine H1 receptor antagonistANTAGONISTChEMBL
BROMPHENIRAMINECHEMBL811Histamine H1 receptor antagonistANTAGONISTChEMBL
BROMPHENIRAMINE MALEATECHEMBL1200961Histamine H1 receptor antagonistANTAGONISTChEMBL
BUCLIZINECHEMBL1201271Histamine H1 receptor antagonistANTAGONISTChEMBL
BUCLIZINE HYDROCHLORIDECHEMBL2360580Histamine H1 receptor antagonistANTAGONISTChEMBL
CARBINOXAMINECHEMBL864Histamine H1 receptor antagonistANTAGONISTChEMBL

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3269/drugs